Federated Hermes Inc. Reduces Position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Federated Hermes Inc. reduced its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 70.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,524 shares of the company's stock after selling 99,160 shares during the quarter. Federated Hermes Inc. owned about 0.07% of Bioceres Crop Solutions worth $584,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ballast Asset Management LP bought a new position in Bioceres Crop Solutions in the third quarter valued at about $2,210,000. Polar Capital Holdings Plc bought a new stake in shares of Bioceres Crop Solutions during the 3rd quarter valued at approximately $2,112,000. Mirae Asset Global Investments Co. Ltd. increased its position in Bioceres Crop Solutions by 46.7% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company's stock worth $1,876,000 after purchasing an additional 43,484 shares in the last quarter. Finally, Raymond James & Associates lifted its stake in Bioceres Crop Solutions by 4.9% in the 3rd quarter. Raymond James & Associates now owns 27,567 shares of the company's stock valued at $311,000 after purchasing an additional 1,300 shares during the last quarter. Institutional investors own 17.68% of the company's stock.

Analysts Set New Price Targets

Separately, Roth Mkm boosted their target price on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a "buy" rating in a research note on Friday, February 9th.


Read Our Latest Stock Analysis on BIOX

Bioceres Crop Solutions Trading Up 2.6 %

Shares of BIOX stock traded up $0.31 during mid-day trading on Friday, reaching $12.14. 33,877 shares of the stock traded hands, compared to its average volume of 31,843. The company has a market cap of $762.39 million, a price-to-earnings ratio of 37.94 and a beta of 0.63. The company has a quick ratio of 0.84, a current ratio of 1.24 and a debt-to-equity ratio of 0.33. The stock's fifty day simple moving average is $12.61 and its two-hundred day simple moving average is $12.57. Bioceres Crop Solutions Corp. has a 1-year low of $9.76 and a 1-year high of $14.20.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its earnings results on Thursday, February 8th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.07 by $0.02. The business had revenue of $140.30 million for the quarter, compared to the consensus estimate of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a return on equity of 5.96%. During the same period last year, the company earned ($0.14) EPS. On average, research analysts anticipate that Bioceres Crop Solutions Corp. will post 0.45 EPS for the current fiscal year.

Bioceres Crop Solutions Profile

(Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also

Institutional Ownership by Quarter for Bioceres Crop Solutions (NASDAQ:BIOX)

Should you invest $1,000 in Bioceres Crop Solutions right now?

Before you consider Bioceres Crop Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.

While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: